ATP7B and Wilson disease: The diagnostic performance of REC reported by El Balkhi et al. was 100% in the detection of WD (cut-off: >18.5%), when results were compared with those of 62 healthy subjects, 25 members of the family of WD patients and without mutations in ATP7B, and 45 heterozygote carriers [29].